SCHEMBL2942363

SCHEMBL2942363

O=C(O)C1CCC(CN2CCCC2=O)CC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.45
KDM4E B2RXH2 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KMT2A Q03164 3/20 0.44
PLG P00747 1/20 0.42
PLAT P00750 1/20 0.42
LMNA P02545 1/20 0.42
ALDH1A1 P00352 2/20 0.41
GAA P10253 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HTT P42858 1/20 0.40
PIK3CD O00329 1/20 0.39
BLM P54132 1/20 0.38
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
RXRG P48443 1/20 0.38
POLB P06746 1/20 0.38
TACR1 P25103 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2942362 1.00 TSHR (0.45) TSHRKDM4EL3MBTL1KMT2APLG
SCHEMBL7384750 0.86 KDM4E (0.52) TSHRKDM4EL3MBTL1KMT2APIK3CD
SCHEMBL2946744 0.82 KDM4E (0.41) TSHRKDM4EL3MBTL1KMT2ALMNA
SCHEMBL2946742 0.82 KDM4E (0.41) TSHRKDM4EL3MBTL1KMT2ALMNA
SCHEMBL22340247 0.81 KDM4E (0.47) TSHRKDM4EL3MBTL1KMT2AALDH1A1
SCHEMBL14835319 0.81 L3MBTL1 (0.48) TSHRKDM4EL3MBTL1KMT2APIK3CD
SCHEMBL3051855 0.81 TSHR (0.50) TSHRKDM4EL3MBTL1KMT2AALDH1A1
SCHEMBL4513010 0.79 KDM4E (0.47) TSHRKDM4EL3MBTL1KMT2APIK3CD
SCHEMBL13745122 0.78 KDM4E (0.47) TSHRKDM4EL3MBTL1LMNAALDH1A1
SCHEMBL25192028 0.77 POLB (0.45) L3MBTL1PLGPLATLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1489078-B1 BENZOFURAN DERIVATIVE MITSUBISHI TANABE PHARMA CORP (JP) 2010-01-06 EP disclosed
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 US disclosed
US-7531537-B2 Benzofuran derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-05-12 US disclosed
US-20050282808-A1 Benzofuran derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2005-12-22 US disclosed
EP-1489078-A1 BENZOFURAN DERIVATIVE Tanabe Seiyaku Co., Ltd. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282808-A1 Benzofuran derivative F12, F2, F11 TSHR 2485/4885KDM4E 1427/4885L3MBTL1 4087/4885
US-20090209511-A1 Benzofuran Derivatives F12, F2, F3 TSHR 2452/4885KDM4E 1464/4885L3MBTL1 4101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.